Flumazenil is an imidazobenzodiazepine derivative that functions as a potent benzodiazepine receptor antagonist, indicated to reverse the sedative effects of benzodiazepines following diagnostic or therapeutic… Read more






















Flumazenil is an imidazobenzodiazepine derivative that functions as a potent benzodiazepine receptor antagonist, indicated to reverse the sedative effects of benzodiazepines following diagnostic or therapeutic procedures. This category provides a comprehensive range of reference standards essential for pharmaceutical laboratories conducting analytical testing and method validation. The selection includes the active pharmaceutical ingredient alongside a broad array of pharmacopeial and non-pharmacopeial impurities, such as specific chloro and defluoro variants. Furthermore, the inclusion of stable isotope labelled compounds supports precise impurity profiling and quantitative analysis in rigorous quality control workflows. These materials are critical for ensuring regulatory compliance and maintaining consistent performance in the identification and quantification of Flumazenil-related substances throughout the drug development and manufacturing lifecycle.